Maryvonne Chariot

Title: Maryvonne Chariot: Innovator in Pharmaceutical Formulations

Introduction

Maryvonne Chariot is a notable inventor based in La Ville du Bois, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of slow-release formulations. With a total of 2 patents to her name, her work has had a meaningful impact on medication delivery systems.

Latest Patents

Maryvonne's latest patents include innovative formulations such as "Slow-release pharmaceutical formulations containing mizolastine" and "Sustained release pharmaceutical composition of diltiazem." These patents focus on creating sustained-release pharmaceutical compositions that utilize microparticles coated with a specific mixture of ethyl cellulose and acrylic resin. This innovative approach enhances the effectiveness of the active ingredients in the formulations.

Career Highlights

Throughout her career, Maryvonne has been associated with Synthelabo, where she has played a crucial role in advancing pharmaceutical technologies. Her expertise in developing sustained-release formulations has positioned her as a key figure in the industry.

Collaborations

Maryvonne has collaborated with esteemed colleagues such as Gareth Lewis and Howard Stevens. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Maryvonne Chariot's contributions to pharmaceutical formulations exemplify her dedication to innovation in the field. Her patents reflect a commitment to improving medication delivery systems, ultimately benefiting patients worldwide.